Kansas SB212 establishes a Prescription Drug Affordability Board and Stakeholder Council to review prescription drug costs and set upper payment.
The Prescription Drug Cost and Affordability Review Act creates the Prescription Drug Affordability Board and Prescription Drug Affordability Stakeholder Council within the Kansas Insurance Department. The Board reviews prescription drug costs and sets upper payment limits for drugs that meet specific criteria, such as high wholesale acquisition costs or significant price increases. The Council assists the Board by providing input and expertise from various stakeholders, including manufacturers, employers, and patient advocates.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.